Help Advance Schizophrenia Research
Clinical research study evaluating an investigational long-acting injection treatment for Schizophrenia
Are you currently taking medication for Schizophrenia?
DM Clinical Research is conducting a 68-week Phase 3 study evaluating an investigational long-acting injection medication given once every 28 days for adults with schizophrenia. All study-related care is at no cost, and compensation is provided.
Why Join the Study?
- Investigational monthly injection treatment at no cost
- Regular monitoring by board-certified medical team
- Access to investigational medication as alternative treatment option
- Compensation up to $3,200 for time and travel
- Contribute to medical research
What to expect when I sign up
When you sign up on the form below, one of our highly-trained patient enrollment specialists will contact you to explain more about the research trial. You can then decide if you want to participate, at which point you will be matched to the nearest research clinic for a screening visit.